Why did I seek more?
Knowing that there was a test that could help resolve an indeterminate diagnosis meant the world to me. I would do just about anything to avoid surgery and I trusted my doctor.
Real People
Knowing
Real Answers.
KAREN MELMED
Afirma Patient
This is the Age of Evidence.
Where a new definition of diagnostic truth is changing patient care as we know it. Where physicians and patients can now benefit from the evolution of healthcare and know, by design, the answers they seek.

Veracyte gives patients a clearer path for the future.

We are leading in the Age of Evidence.
our impact
The Age
of Evidence
Veracyte's genomic tests have the potential to save billions of dollars each year in unnecessary surgery costs.
Learn More >
Highlighted by National Cancer Institute
NCI highlights lung cancer early detection work behind Percepta in its annual plan
learn more >
Answers That Set New Standards
Veracyte’s CEO named as one of 2017’s Fiercest Women in Life Sciences

learn more >


latest news
news and updates
Dec 4, 2017
Veracyte’s CEO Named as one of 2017’s Fiercest Women in Life Sciences

learn more >
Nov 28, 2017
Veracyte Announces Publication of Data Confirming Analytical Validity of Envisia Genomic Classifier for Use in IPF Diagnosis

learn more >
Nov 21, 2017
Next Generation Genomic Sequencer Improves Thyroid Cancer Diagnosis

learn more >